Table 3 Baseline patient demographic data
|  | Intraoperative intravitreal conbercept (n = 15) (mean ± SD) | Control group (n = 15) (mean ± SD) | P value |
|---|---|---|---|
Mean age, (yrs) | 55.54 ± 9.94 | 53.5 ± 9.59 | 0.57 |
Gender (male/female) | 6/9 | 10/5 | 0.3 |
Duration of diabetes, (y) | 13.19 ± 8.08 | 9.88 ± 8.52 | 0.32 |
Hypertension | 7/15(46.7%) | 5/15(33.3%) | 0.71 |
Lens status (Phakic/pseudophakic) | 12/3 | 14/1 | 0.6 |
IOP (mmHg) | 12.46 ± 3.26 | 12.3 ± 1.44 | 0.88 |
HbA1c at time of surgery | 6.65 ± 1.13 | 6.8 ± 1.00 | 0.7 |
Preoperative pan-retinal photocoagulation history | Â | Â | 0.9 |
 None | 5(33.3%) | 4(26.7%) |  |
 Incomplete | 6(40%) | 6(40%) |  |
 complete | 4(26.7%) | 5(33.3%) |  |
Preoperative VH grades | Â | Â | 0.47 |
 1 | 1(6.7%) | 2(13.3%) |  |
 2 | 5(33.3%) | 2(13.3%) |  |
 3 | 3(20%) | 6(40%) |  |
 4 | 6(40%) | 5(33.3%) |  |
Preoperative BCVA (logMAR) | 2.02 ± 0.8 | 1.62 ± 0.69 | 0.18 |
Extent of vitreoretinal adhesion grade | Â | Â | 0.91 |
 0 | 2(13.3%) | 2(13.3%) |  |
 1 | 3(20%) | 4(26.7%) |  |
 2 | 10(66.7%) | 9(60%) |  |
 3 | 0 | 0 |  |